Genetic polymorphisms of platelet adhesive molecules: Association with breast cancer risk and clinical presentation

Breast Cancer Research and Treatment

Volumn 80, Issue 2, 2003, Pages 145-154

  Ayala, Francisco ^b   Corral, Javier ^a   González Conejero, Rocío ^a   Sánchez, Ignacio ^a   Moraleda, José María ^b   Vicente, Vicente ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b NONE

Author keywords

Breast cancer; Genetic polymorphism; Glycoprotein Ib , integrin 2, integrin 3

Indexed keywords

ALPHA2 INTEGRIN; BETA3 INTEGRIN; GLYCOPROTEIN IB; INTEGRIN; INTEGRIN ALPHA2BBETA3; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER SIZE; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL INTERACTION; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SPAIN;

EID: 0037998722     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024598732178     Document Type: Article

References (43)

1. Hung M, Lau Y: Basic science of HER-2/neu: a review. Semin Oncol 26(S12): S51-S59, 1999
2. Honn KV, Tang DG, Chen YQ: Platelets and cancer metastasis: more than an epiphenomenon. Semin Thromb Hemost 18: 392-415, 1992
3. Nierodzik ML, Klepfish A, Kaspatkin S: Role of the platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand Factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74: 282-290, 1995
4. Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B, Varon D: Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha (v) integrins. Int J Cancer 70: 201-207, 1997
5. Oleksowicz L, Mrowiec Z, Schwartz E, Khorshidi M, Dutcher JP, Puszkin E: Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thromb Res 79: 261-274, 1995
6. 1 integrin cell-surface collagen receptor. Am J Pathol 137: 113-120, 1990
7. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R: Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br J Cancer 75: 623-633, 1997
8. Grossi IM, Hatfield JS, Fitzgerald LA, Newcombe M, Taylor JD, Honn KV: Role of tumor cell glycoproteins inmunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 2: 2385-2395, 1988
9. Zutter MM, Krigman HR, Santoro SA: Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol 142: 1439-1448, 1993
10. Gui GPH, Wells CA, Yeomans P, Jordan SE, Vinson GP, Carpenter R: Integrin expression in breast cancer cytology: a novel predictor of axillary metastasis. Eur J Surg Oncol 22: 254-258, 1996
11. Oleksowicz L, Bhagwati N, Fernández MD, Seno R, Etkind P: Prognostic significance of platelet inmunorelated GPIb expression in breast cancer. Cancer J Sci Am 4: 247-253, 1998
12. Bray PF: Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 7: 284-289, 2000
13. 1 density. Blood 92: 2382-2388, 1998
14. Corral J, Rivera J, González-Conejero R, Vicente V: The platelet GP Ia receptor density associates with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39: 372-378, 1999
15. 2 subunit of VLA-2). Br J Hematol 86: 671-674, 1994
16. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmitt-Clermont PJ: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334: 1090-1094, 1996
17. A2 and coronary risk: a meta-analysis. Thromb Haemost 85: 626-633, 2001
18. González-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V: Polymorphisms of platelet membrane glycoprotein Ibα associated with arterial thrombotic disease. Blood 92: 2771-2776, 1998
19. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW (eds): AJCC Cancer Staging Handbook. 5th edn, Lippincott, Philadelphia, 1998, pp 159-170
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edn, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989
21. Takada Y, Hemler ME: The primary structure of the VLA-2/collagen receptor alpha-2 subunit (platelet GP Ia): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 109: 397-407, 1989
22. Corral J, Iniesta JA, González-Conejero R, Vicente V: Detection of Factor V Leiden from a drop of blood by PCR-SSCP. Thromb Haemost 76: 735-737, 1996
23. Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller Eckhardt C: Localization of the Br polymorphism on a 144 bp exon of the GP Ia gene and its application in platelet DNA typing. Thromb Haemost 71: 651-654, 1994
24. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ: Hereditary variations in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 89: 1939-1943, 1997
25. 145. Blood 86: 1356-1360, 1995
26. Simsek S, Faber NM, Bleeker PM, Vlekke ABJ, Huiskes E, Goldschmeding R, von dern Borne AEG: Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 81: 835-840, 1993
27. Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidem Biom Prev 8: 843-854, 1999
28. Howe A, Aplin AE, Alahari SK, Juliano RL: Integrin signaling and cell growth control. Curr Opin Cell Biol 10: 220-231, 1998
29. Tuszynski GP, Wang TN, Berger D: Adhesive proteins and the hematogenous spread of cancer. Acta Haematol 97: 29-39, 1997
30. Alford D, Pitha-Rowe P, Taylor-Papadimitriou J: Adhesion molecules in breast cancer: role of α2β1 integrin. Biochem Soc Symp 63: 245-259, 1998
31. Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J: Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 107: 3557-3568, 1994
32. 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92: 7411-7415, 1995
33. Chen YQ, Trikha M, Gao X, Bazaz R, Porter AT, Timar J, Hohn KV: Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. Int J Cancer 72: 642-648, 1997
34. Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD: Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa and of platelet α-granule proteins in platelet aggregation induced by human osteosarcoma cells. Cancer Res 53: 4695-4700, 1993
35. 2 integrin gene promoter: identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J Biol Chem 269: 463-469, 1994
36. 2 gene. Blood 97: 1721-1726, 2001
37. 2 integrin gene core promoter activity. Blood 90: 678-689, 1997
38. 2-integrin expression in human mammary epithelial cells. Mol Cell Biol 16: 6178-6189, 1996
39. 2). J Clin Invest 92: 2427-2432, 1993
40. A2 polymorphism: the Framingham Offspring Study. Artherioscler Thromb Vasc Biol 19: 1142-1147, 1999
41. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF: Platelet GPIIIa P1(A) polymorphisms display different sensitivities to agonists. Circulation 101: 1013-1018, 2000
42. Meyer T, Marshall JF, Hart IR: Expression of alphav integrins and vitronectin receptor identity in breast cancer cells. Br J Cancer 77: 530-536, 1998
43. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001